Agilon Health, Inc.
AGL · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$110,207 | -$104,370 | $12,112 | -$105,790 |
| Dep. & Amort. | $7,430 | $7,319 | $6,876 | $6,494 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $15,381 | $16,720 | $2,282 |
| Change in WC | $92,722 | $52,875 | -$38,794 | $105,765 |
| Other Non-Cash | -$8,099 | -$6,290 | -$28,901 | $7,668 |
| Operating Cash Flow | -$18,154 | -$35,085 | -$31,987 | $16,419 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$16,534 | -$5,933 | -$3,849 | -$3,266 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$12,637 | -$47,517 | $0 |
| Inv. Sales/Matur. | $35,192 | $90,028 | $35,311 | $40,087 |
| Other Inv. Act. | $0 | -$1,000 | -$7,034 | -$13,148 |
| Investing Cash Flow | $18,658 | $70,458 | -$23,089 | $23,673 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$22 |
| Stock Repurch. | -$236 | -$2,580 | -$161 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$236 | -$2,580 | -$161 | -$22 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $268 | $32,793 | -$55,237 | $40,070 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $171,416 | $138,623 | $193,860 | $153,790 |
| End Cash | $171,684 | $171,416 | $138,623 | $193,860 |
| Free Cash Flow | -$21,329 | -$38,335 | -$42,870 | $3,996 |